US0441861046 - Common Stock

Overall **ASH** gets a fundamental rating of **5** out of 10. We evaluated **ASH** against 86 industry peers in the **Chemicals** industry. Both the profitability and the financial health of **ASH** get a neutral evaluation. Nothing too spectacular is happening here. **ASH** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **ASH** had a positive cash flow from operations.

The **Return On Assets** of **ASH** (**3.95%**) is comparable to the rest of the industry.

Looking at the **Return On Equity**, with a value of **7.56%**, **ASH** is in line with its industry, outperforming **50.00%** of the companies in the same industry.

The **Return On Invested Capital** of **ASH** (**3.89%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.95% | ||

ROE | 7.56% | ||

ROIC | 3.89% |

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)4.01%

ROIC(5y)3.91%

In the last couple of years the **Gross Margin** of **ASH** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 10.75% | ||

PM | 10.32% | ||

GM | 32.52% |

OM growth 3Y11.97%

OM growth 5Y6.15%

PM growth 3Y24.16%

PM growth 5Y289.39%

GM growth 3Y4.61%

GM growth 5Y1.8%

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), **ASH** is destroying value.

The debt/assets ratio for **ASH** has been reduced compared to a year ago.

An Altman-Z score of **2.46** indicates that **ASH** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Debt to FCF ratio of **ASH** is **27.67**, which is on the high side as it means it would take **ASH**, **27.67** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.42** indicates that **ASH** is not too dependend on debt financing.

The **Debt to Equity ratio** of **ASH** (**0.42**) is better than **61.63%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.42 | ||

Debt/FCF | 27.67 | ||

Altman-Z | 2.46 |

ROIC/WACC0.83

WACC8.85%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.53 | ||

Quick Ratio | 1.88 |

Looking at the last year, **ASH** shows a quite strong growth in **Revenue**. The Revenue has grown by **10.60%** in the last year.

The **Revenue** has been growing slightly by **0.70%** on average over the past years.

EPS 1Y-7.29%

EPS 3Y31.67%

EPS 5Y5.04%

EPS growth Q2Q-34.92%

Revenue growth 1Y10.6%

Revenue growth 3Y-1.38%

Revenue growth 5Y0.7%

Revenue growth Q2Q-15.22%

The **Earnings Per Share** is expected to grow by **8.80%** on average over the next years. This is quite good.

Based on estimates for the next years, **ASH** will show a small growth in **Revenue**. The Revenue will grow by **3.82%** on average per year.

EPS Next Y-18%

EPS Next 2Y0.82%

EPS Next 3Y7.21%

EPS Next 5Y8.8%

Revenue Next Year-7.37%

Revenue Next 2Y-1.04%

Revenue Next 3Y1.5%

Revenue Next 5Y3.82%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

With a **Price/Earnings** ratio of **16.34**, **ASH** is valued correctly.

The **Price/Forward Earnings** ratio is **14.28**, which indicates a correct valuation of **ASH**.

The average S&P500 **Price/Forward Earnings** ratio is at **19.01**. **ASH** is valued slightly cheaper when compared to this.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.34 | ||

Fwd PE | 14.28 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **ASH** indicates a slightly more expensive valuation: **ASH** is more expensive than 61.63% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 88.76 | ||

EV/EBITDA | 10.74 |

PEG (NY)N/A

PEG (5Y)3.24

EPS Next 2Y0.82%

EPS Next 3Y7.21%

Compared to the average S&P500 **Dividend Yield** of **2.58**, **ASH** is paying slightly less dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.83% |

The dividend of **ASH** has a limited annual growth rate of **0.31%**.

Dividend Growth(5Y)0.31%

Div Incr Years13

Div Non Decr Years13

DP31.09%

EPS Next 2Y0.82%

EPS Next 3Y7.21%

**ASHLAND INC**

NYSE:ASH (9/22/2023, 7:04:00 PM)

After market: 83.15 0 (0%)**83.15**

**-0.83 (-0.99%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)07-25 2023-07-25/amc

Earnings (Next)11-06 2023-11-06/amc

Inst Owners91.5%

Inst Owner Change-1.85%

Ins Owners0.3%

Ins Owner Change2.14%

Market Cap4.26B

Analysts75

Price Target105.8 (27.24%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.83% |

Dividend Growth(5Y)0.31%

DP31.09%

Div Incr Years13

Div Non Decr Years13

Ex-Date08-31 2023-08-31 (0.385)

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-4.93%

Min EPS beat(2)-5.63%

Max EPS beat(2)-4.23%

EPS beat(4)1

Avg EPS beat(4)-2.65%

Min EPS beat(4)-5.63%

Max EPS beat(4)2.25%

Revenue beat(2)2

Avg Revenue beat(2)97057%

Min Revenue beat(2)95289.5%

Max Revenue beat(2)98824.6%

Revenue beat(4)4

Avg Revenue beat(4)97780.2%

Min Revenue beat(4)95289.5%

Max Revenue beat(4)99582.1%

PT rev (1m)0%

PT rev (3m)-11.5%

EPS NQ rev (1m)-3.34%

EPS NQ rev (3m)-45.59%

EPS NY rev (1m)0%

EPS NY rev (3m)-27.07%

Revenue NQ rev (1m)-99.9%

Revenue NQ rev (3m)-99.91%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-11.65%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 16.34 | ||

Fwd PE | 14.28 | ||

P/S | 1.85 | ||

P/FCF | 88.76 | ||

P/OCF | 21.85 | ||

P/B | 1.35 | ||

P/tB | 5.01 | ||

EV/EBITDA | 10.74 |

EPS(TTM)5.09

EY6.12%

EPS(NY)5.82

Fwd EY7%

FCF(TTM)0.94

FCFY1.13%

OCF(TTM)3.81

OCFY4.58%

SpS45

BVpS61.45

TBVpS16.59

PEG (NY)N/A

PEG (5Y)3.24

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.95% | ||

ROE | 7.56% | ||

ROCE | 4.43% | ||

ROIC | 3.89% | ||

ROICexc | 4.15% | ||

ROICexgc | 7.39% | ||

OM | 10.75% | ||

PM | 10.32% | ||

GM | 32.52% | ||

FCFM | 2.08% |

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)4.01%

ROIC(5y)3.91%

ROICexc(3y)4.36%

ROICexc(5y)4.17%

ROICexgc(3y)8.22%

ROICexgc(5y)8.13%

ROCE(3y)4.57%

ROCE(5y)4.46%

ROICexcg growth 3Y14.93%

ROICexcg growth 5Y12.4%

ROICexc growth 3Y19.96%

ROICexc growth 5Y15.27%

OM growth 3Y11.97%

OM growth 5Y6.15%

PM growth 3Y24.16%

PM growth 5Y289.39%

GM growth 3Y4.61%

GM growth 5Y1.8%

F-Score5

Asset Turnover0.38

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.42 | ||

Debt/FCF | 27.67 | ||

Debt/EBITDA | 2.72 | ||

Cap/Depr | 61.25% | ||

Cap/Sales | 6.37% | ||

Profit Quality | 20.17% | ||

Current Ratio | 3.53 | ||

Quick Ratio | 1.88 | ||

Altman-Z | 2.46 |

F-Score5

WACC8.85%

ROIC/WACC0.83

Cap/Depr(3y)48.6%

Cap/Depr(5y)51.15%

Cap/Sales(3y)5.21%

Cap/Sales(5y)5.57%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-7.29%

EPS 3Y31.67%

EPS 5Y5.04%

EPS growth Q2Q-34.92%

EPS Next Y-18%

EPS Next 2Y0.82%

EPS Next 3Y7.21%

EPS Next 5Y8.8%

Revenue growth 1Y10.6%

Revenue growth 3Y-1.38%

Revenue growth 5Y0.7%

Revenue growth Q2Q-15.22%

Revenue Next Year-7.37%

Revenue Next 2Y-1.04%

Revenue Next 3Y1.5%

Revenue Next 5Y3.82%

EBIT growth 1Y-10.14%

EBIT growth 3Y10.43%

EBIT growth 5Y6.89%

EBIT Next Year45.41%

EBIT Next 3Y22.4%

EBIT Next 5YN/A

FCF growth 1Y-88.78%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-64.29%

OCF growth 3YN/A

OCF growth 5YN/A